Related Experiment Video
Updated: Jun 24, 2026
10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Langerhans cell histiocytosis: an update
1Department of Dermatology, General Hospital of Alicante, Spain. mataixdiaz@hotmail.com
Summary
Langerhans cell histiocytosis (LCH) is a complex disorder of histiocyte proliferation. This review updates current understanding and recommendations for classifying, evaluating, and treating LCH.
Area of Science:
- Histiocytosis
- Pediatric Hematology/Oncology
- Immunology
Background:
- Histiocytoses involve abnormal histiocyte proliferation in tissues.
- Langerhans cell histiocytosis (LCH) is the most frequent type, impacting children significantly.
- LCH pathogenesis remains unclear, suggesting neoplastic, reactive, or immune dysregulation origins.
Purpose of the Study:
- To provide an updated review of Langerhans cell histiocytosis (LCH).
- To emphasize current recommendations for LCH classification, evaluation, and treatment.
Main Methods:
- Literature review of recent studies on LCH.
- Synthesis of current clinical guidelines and expert opinions.
Main Results:
- LCH presents a wide clinical spectrum, from self-resolving to fatal multisystem disease.
- Current understanding points to LCH as a complex disorder with varied presentations.
- Recent advancements aid in better classification and evaluation.
Conclusions:
- Accurate classification, evaluation, and treatment are crucial for managing LCH.
- Continued research is needed to fully elucidate LCH pathogenesis and optimize therapies.
- This review offers a current perspective for clinicians managing LCH patients.
